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Prevalence and predictors of depression, anxiety, and 
stress symptoms among pregnant women during 




Several studies have been published on the topic of  COVID-19 and pregnancy over recent months. However, few studies have 
evaluated the impact of  this pandemic on maternal mental health, particularly in low-resource settings.
Aim
To determine the prevalence and predictors of  COVID-19-related depression, anxiety and stress symptoms among pregnant women.
Methods
This was a cross-sectional study that involved 456 pregnant women attending prenatal care at Abakaliki, Nigeria, during the COVID-19 
lockdown. These patients were screened for psychological morbidities using the Depression Anxiety and Stress Scale-21 (DASS-21). 
Results
Severe and extremely severe depression were reported in 7.2% (n=33) and 6.4% (n=29) of  participants, respectively. Analysis also 
revealed that 3.3% (n=15) and 7.7% (n=35) of  women had severe and extremely severe anxiety, respectively. In total, 23% (n=105) 
of  the participating women had severe stress while 16.7% (n=76) reported extremely severe stress. Multiparity (2–4) and occupation, 
such as trading and farming, were predictors of  depression whereas grand-multiparity, urban residence, and trading, were identified as 
predictors of  anxiety and stress.
Conclusion
Symptoms of  depression, anxiety and stress were relatively common among pregnant women during the COVID-19 lockdown in 
Abakaliki, Nigeria. There is a clear need to integrate screening for depression, anxiety and stress, in existing antenatal care programs so 
as to identify and prevent long-term adverse psychological outcomes related to the COVID-19 pandemic.
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Introduction
In December 2019, a series of  pneumonia cases caused by 
severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) emerged in Wuhan, China1. This infection has 
spread to over 110 countries, including Nigeria, prompting 
the World Health Organization (WHO) to declare a 
pandemic on 11 March 2020. The Nigeria Centre for 
Disease Control announced the first confirmed case of  
coronavirus disease in Nigeria on 27 February2020; since 
then, many confirmed cases have been reported in all of  
the States across the country2. By 24 August 2020, there had 
been 52,548 confirmed cases and 1004 deaths from SARS-
CoV-2 infection in Nigeria2.
Under normal circumstances, approximately 10% of  
pregnant women suffer from mental disorders, particularly 
depression3 when calculated on a global basis although this 
figure has been reported to be higher (16%) in developing 
nations4. The prevalence of  such disorders may have been 
aggravated during the coronavirus disease 2019 (COVID-19) 
pandemic because pregnant women may have experienced 
restricted access to mental health services. The mental health 
impact of  the COVID-19 pandemic on childbearing women 
is a major public health challenge and requires appropriate 
and timely health care support to avert adverse health 
outcomes; at present, this issue is a significantly under-
represented research area5.
Information relating to the potential long-term physical 
and psychological impacts of  the COVID-19 pandemic on 
pregnant women and the fetus have yet to be fully elucidated. 
However, studies on the psychological effects of  the SARS 
outbreak in 2003 on the experience of  pregnant women 
showed that in addition to physical health implications, these 
women experienced high levels of  depression, anxiety and 
stress with regards to potential infection6. Anxiety over the 
pregnant woman’s own health and that of  the fetus may have 
detrimental effects on maternal and fetal well-being7. 
Anxiety is common during and after pregnancy as women 
anticipate and adjust to motherhood, especially in those 
women and couples who have previously experienced 
adverse pregnancy outcomes, such as miscarriage and 
perinatal death8,9. The COVID-19 pandemic has resulted 
in fear, anxiety and concern in many nations as a result 
of  the pandemic itself10,11, but also due to the restrictive 
public health measures implemented to reduce community 
transmission. Border closures, travel bans, quarantine 
measures, and physical distancing have resulted in increased 
levels of  isolation and reduced access to, and interaction with, 
social supports and networks12,13. This is likely to result in 
increased levels of  stress, anxiety, loneliness and depression, 
particularly for pregnant women who will have an added level 
Malawi Medical Journal 33 (1); 54-58 March 2021 Depression, anxiety, stress and COVID-19-lockdown 55
https://dx.doi.org/10.4314/mmj.v33i1.8
of  concern about their own health and the protection of  
their unborn baby. Empirical evidence suggests that prenatal 
stress is related to higher rates of  adverse birth outcomes, 
such as preterm delivery, low birth weight, and a high rate of  
caesarean section14.
In order to prevent transmission of  COVID-19, measures 
and guidelines were altered in the management of  many 
patients, including pregnant women. This particular group 
of  patients is likely to be affected by the significant changes 
in the management of  pregnancy, labour, birth and postnatal 
care provided by health services including a reduction in face-
to-face appointments and increased use of  telemedicine9. 
Studies have shown that lockdown is creating significant 
stress on pregnant women with consequential effects on 
the maternity providers (obstetricians, midwives, nurses and 
allied health professionals) caring for them15. In Nigeria, the 
psychological impact of  these measures on pregnant women 
has yet to be described. 
The objectives of  this study were to determine the prevalence 
and associated factors of  depression, anxiety and stress 
among pregnant women attending for prenatal care in a 
tertiary health institution in Abakaliki during the COVID-19 
lockdown in Nigeria. 
Materials and methods
Study design, period and setting
This was a cross-sectional study conducted from 1 March 
2020 to 31 July 2020 at the antenatal clinic of  Alex Ekwueme 
Federal University Teaching Hospital, Abakaliki, Nigeria. 
This hospital manages approximately 4500 deliveries 
annually and receives referral from all parts of  the state and 
the neighbouring states of  Benue, Enugu, Cross River and 
Abia, as well as any other part of  the country16.
Study participants and criteria
The study participants were pregnant women in all trimesters 
of  gestation attending for prenatal care at the study facility 
during the study period. Women who gave consent to 
participate in the study were included. Those with a history 
of  psychiatric illness, or conditions that limit their ability to 
understand the study questions, were excluded.
Sampling technique and recruitment 
A total sampling method was used in the study and consecutive 
pregnant women who were attending for antenatal care were 
approached to participate in the study. Due to the lack of  
data on the prevalence of  depression, anxiety and stress 
symptoms among our pregnant population, we decided to 
use a total sampling method. The sampling was performed 
by acquiring the attendance register of  pregnant women 
attending for prenatal care during weekdays as the women 
presented. All pregnant women attending for prenatal care 
at the study facility were informed about the study and were 
asked to participate in the study. After consultation with a 
doctor, a questionnaire was offered to all eligible women 
in the attendance register. The women completed the 
questionnaire and returned it to the researchers or research 
assistants for analysis. 
Sample size determination
It was important that we determined the adequate sample size 
for each condition (depression, anxiety and stress). Taking 
the prevalence (p) of  depression among pregnant women to 
be 13.5%, as based on a study reported by Taubman-Ben-
Ari et al.,7 the sample size required was 208 considering a 
precision of  5% and a design effect of  1.5 using OpenEpi 
software17, If  estimated considering the prevalence of  stress 
(p=29.8%) and anxiety (p=24.1%), the sample size, with the 
other assumptions remaining constant, were 315 and 288, 
respectively. Considering the largest value of  the three, 315, 
and assuming that approximately 10% of  questionnaires will 
have incomplete responses, the sample size was estimated to 
be 346.5. However, to increase the power of  the study, we 
recruited 456 pregnant women.
Data collection and analysis
Data were collected using a self-administered structured 
questionnaire. The questionnaire had two components: 
sociodemographic characteristics and the Depression 
Anxiety and Stress Scale-21 (DASS-21).
The sociodemographic variables collected were age, parity, 
marital status (single, married, divorced or widowed), area of  
residence (rural or urban), educational level attainment (no 
formal education, primary, secondary or tertiary), occupation 
(housewife, farmer, trader, artisan, or civil servant), and the 
semester of  gestation.
The DASS-21 is a self-reporting questionnaire that features 
21 items; 7 items per subscale of  depression, anxiety and 
stress18. This questionnaire has been used in different 
populations to assess depression, anxiety, and stress 
symptoms, in the ongoing COVID-19 pandemic10,11,14. In 
completing the DASS-21, each individual was required to 
indicate the presence of  a symptom over the previous week. 
Each item was scored from 0 (“did not apply to me at all 
over the past week”) to 3 (“applied to me very much or 
most of  the time over the past week”). In this tool, a 4-point 
severity scale was used to assess the state of  the participants 
in the three subscales over the previous week. Each score 
was multiplied by 2 and the final scores were assessed against 
the DASS severity ratings (Table 1).
The survey questionnaire, and the consent form in English, 
were translated into Igbo language, and then back-translated 
to English to check for semantic equivalence. The reliability 
of  the questionnaire was checked by conducting a pre-test 
among pregnant women in the antenatal clinic; this was 
undertaken in 5% of  the sample size. Using the pre-test data, 
we were able to investigate the understandability, clarity and 
organization of  the questionnaire. The reliability test yielded 
a Cronbach’s alpha value of  0.896.
All returned questionnaires were checked manually for 
completeness and consistency of  responses. The collected 
data were entered and analysed using SPSS version 22 (IBM 
Corp. Amork, New York, USA). Continuous variables 
are presented as means ± standard deviations (SDs) 
while categorical variables are summarized as numbers 
and percentages. Multivariate logistic regression analysis, 
presented with  odds ratios (OR) and 95% confidence 
intervals (CI), was used to identify sociodemographic factors 
associated with psychological morbidities. P values <0.05 
were considered to be statistically significant.
Ethical considerations
This study was approved by the Research and Ethics 
Committee of  the Alex Ekwueme Federal University Teaching 
Hospital, Abakaliki. Informed consent was taken from the 
study participants after informing the study participants with 
regards to the objectives, expected outcomes and benefits of  
the study. All responses remained confidential.
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Results
In total, 456 women participated in this study. The mean 
age of  the participants was 27 ± 12.6 years; the age range 
was 18–45 years, and the modal age was 28–37 years. The 
majority of  the participants were married (87.9%), parity 
(para) 2–4 (36.2%), resided in urban areas (61.2%), had 
received secondary education (49.1%), were traders (38.4%), 
and were in the 2nd trimester of  gestation (45.8%) (Table 2).
Table 3 shows the prevalence of  various psychological states 
of  the study cohorts. DASS-21 assessment showed that 
depression was reported in 45.2% (n=206) of  participants: 
31.6% (n=144) had mild-to-moderate depression, 7.2% 
(n=33) had severe depression, and 6.4% (n=29) had 
extremely severe depression. We also found that 37.5% 
(n=171) of  the women surveyed reported anxiety symptoms. 
Of  these, mild-to-moderate anxiety was reported by 26.5% 
(n=121) of  participants. Severe and extremely severe anxiety 
were reported by 3.3% (n=15) and 7.7% (n=35) of  the study 
participants, respectively. Of  the 456 participants, 56.8% 
(n=259) reported stress symptoms. Analysis also showed 
that 17.1% (n=78) of  women reported mild-to-moderate 
stress symptoms; 23% (n=105) and 16.7% (n=76) reported 
severe and extremely severe stress, respectively.
Table 4 depicts multivariable logistic regression for predictors 
of  depression, anxiety and stress among the participants. 
The sociodemographic characteristics of  the participants 
had variable effects on the development of  psychological 
symptoms relating to depression, anxiety and stress. Women 
aged between 38–45 years were three times more likely to 
develop depression when compared to those between 18 
and 27 years (OR=3.1, 95% CI: 0.06–0.19, P<0.001). Other 
factors that were significantly associated with depression 
among pregnant women during COVD-19 lockdown were 
being para 2–4 (OR=1.9, 95% CI: 1.16–3.31, P=0.011), and 
having an occupation that required physical contact, such 
as being a farmer (OR=1.9, 95% CI: 1.01–3.52, P=0.047), 
trader (OR=3.4, 95% CI: 0.24–0.71, P=0.001), or an artisan 
(OR=5.1, 95% CI: 0.05–0.36, P<0.001). Factors that were 
significantly associated with a lower risk of  depression among 
the participants were being aged 18–27 years (OR=0.6, 95% 
CI: 0.37–0.9, P=0.016), para 1 (OR=0.5, 95% CI: 0.31–0.94, 
P=0.028), divorced (OR=0.2, 95% CI: 0.05–0.93, P=0.04), 
and working as a civil servant (OR=0.5, 95% CI: 2.23–13.6, 
P<0.001). 
Variables that were significantly associated with anxiety 
included an age of  38–45 years (OR=2.2, 95% CI: 0.1–0.3, 
P<0.001), para 5 and above (OR=4.1, 95% CI: 0.07–0.26, 
P<0.001), urban residence (OR=2.6, 95% CI: 0.39–0.87, 
P=0.008), tertiary education (OR=3.8, 95% CI: 0.12–0.39, 
P=0.001), and working as a trader (OR=4.2, 95% CI: 0.12–
0.39, P<0.001).
Higher parity (≥5), urban residence, and being in the 3rd 
trimester of  gestation were all significantly associated with 
the risk of  developing stress symptoms. Grand-multiparous 
women were nearly six times more likely to report stress 
symptoms when compared to nulliparous participants 
(OR=5.9, 95% CI: 2.99–11.9, P<0.001). Furthermore, 
participants who lived in urban centres were three times 
more likely to report stress symptoms when compared with 
those living in rural areas (OR=3.3, 95% CI: 0.18–0.39, 
P<0.001). Stress was almost twice as high in women in their 
3rd trimester of  pregnancy when compared to those in their 
1st trimester (OR=1.9, 95% CI: 1.05–3.29, P=0.034).
Severity Depression Anxiety Stress
Normal 0–9 0–7 0–14
Mild 10–13 8–9 15–18
Moderate 14–20 10–14 19–25
Severe 21–27 15–19 26–33
Extremely severe ≥28 ≥20 ≥34






























Civil servant 63 (13.8)
Semester of gestation
1st trimester 88 (19.3)
2nd trimester 209 (45.8)
3rd trimester 159 (34.9)
Table 2. Sociodemographic characteristics of the participants 
(N=456)


















Extremely severe 76 (16.7)
Table 3. Psychological outcomes of the participants (N=456), as 
determined by the DASS-21
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Discussion
Several studies on COVID-19 and pregnancy have been 
published recently. However, very few studies have evaluated 
the impact of  this pandemic on maternal mental health, 
particularly in a low-resource setting. In this study, we 
evaluated the prevalence of  depression, anxiety, and stress, 
among pregnant women during COVID-19 lockdown.
We found high levels of  depression (45.2%) among our study 
participants. Pregnant women who were between the ages of  
38 and 45 years, para 2–4, and those who had occupations 
that required physical contact, such as trading, were more 
likely to be affected. Over one-third (37.5%) of  the pregnant 
women surveyed reported COVID-19-related anxiety. Similar 
findings were reported by Taubman-Ben-Ari et al. in Israel 
where a significant number of  pregnant women reported 
COVID-19-related anxiety; the greatest concern was related 
to being in public places or taking public transport7. This 
was followed by anxieties relating to the health of  others, 
either the fetus or family members, and then the possibility 
of  the pregnant woman herself  being infected, and anxiety 
relating to delivery. Although the same anxieties were shared 
by pregnant women experiencing diverse sociodemographic 
variables, the COVID-19 lockdown had resulted in low 
economic activity and difficulty accessing transportation in 
the event of  emergency. These conditions are likely to make 
a pregnant woman feel less secure and therefore feel more 
anxious and distressed in the face of  the current crisis.
Similarly, over half  (56.8%) of  the 
participants reported stress symptoms. 
High parity (≥5), urban residence and 
being in 3rd trimester gestation were 
significantly associated with risk of  
developing stress symptoms. This is not 
surprising as women in these groups 
need social support to lighten the 
burden of  pregnancy. Social distancing 
has resulted in inadequate social support 
for many pregnant women as they are 
separated from their loved ones, whom 
they rely on for support during this 
critical phase. While social support 
helps pregnant women to relieve stress, 
inadequate social support is one of  
the significant risk factors for extreme 
stress and depression among pregnant 
women.
Occupations requiring physical 
contacts, such as being a farmer, were 
associated with adverse mental health. 
In the present study, pregnant mothers 
who were farmers and residing in rural 
areas were at high risk of  developing 
COVID-19-related depression, anxiety 
and stress. This is probably because 
the lockdown limited the ability of  the 
rural population to procure essential 
services such as transportation to 
access emergency healthcare services 
that might not be available in the local 
communities. In addition, poor or a 
lack of  palliative support during the 
lockdown period for rural households (for many of  which 
women are the breadwinners), might be responsible for 
adverse psychological morbidities among pregnant women in 
rural settings. Therefore, training village healthcare workers 
on how to screen and detect psychological morbidities 
among at-risk pregnant women would aid timely referral 
for treatment and help to prevent prolonged adverse mental 
outcomes resulting from the COVID-19 pandemic22. 
The long-term mental health outcome of  COVID-19 is not 
yet known and it may take months to become completely 
evident. To provide adequate support to pregnant women in 
developing countries, in which only a minimal mental health 
service is available, there is a need to integrate screening 
for anxiety, stress and depression among the existing 
antenatal care programs. A detailed mental health crisis 
program should also be developed by introducing innovative 
strategies such as tele-consultation services to provide 
psychological assistance, for example cognitive behaviour 
therapy, to pregnant mothers in order to deal with secondary 
mental health challenges related with COVID-19.23 There is 
a need for further research to investigate the impact of  the 
COVID-19 pandemic on pregnant women and their babies, 
particularly in developing countries where mental health care 
is poorly developed. Culture-sensitive intervention programs 
should be put in place and taught to healthcare workers, 
such as nurses and midwives, for the early intervention 
of  pregnant women suffering from COVID-19-related 
psychological distress. 
Table 4. Multivariable logistic regression analysis showing the predictors of depression, anxiety and stress, among the participants
Variable Depression Anxiety Stress
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Age, years
18–27 1.00 1.00 1.00











0 1.00 1.00 1.00
















Single 1.00 1.00 1.00
















Rural 1.00 1.00 1.00


























Housewife 1.00 1.00 1.00





















1st trimester 1.00 1.00 1.00










Malawi Medical Journal 33 (1); 54-58 March 2021 Depression, anxiety, stress and COVID-19-lockdown 58
https://dx.doi.org/10.4314/mmj.v33i1.8
Although pregnancy is a time of  joy for most women, some 
women experience a range of  negative emotions during 
pregnancy, thus leading to anxiety and depression19. Maternal 
mental health problems are associated with short-term and 
long-term risks for the affected mothers’ overall health and 
function, as well as the physical, cognitive and psychological 
development, of  the child20. Certain conditions, such as 
extreme stress, emergencies and conflict situations, and 
natural disasters, can inflate the risks of  perinatal mental 
health morbidity21. Therefore, it is plausible that pregnant 
women are vulnerable to mental ill-health during the 
COVID-19 pandemic.
This study has a limitation that needs to be considered: 
this was a single-centre study that cannot be considered to 
be representative of  the population of  pregnant women 
across the whole of  Nigeria during the lockdown period. A 
multicentre study would have improved the generalization 
of  the study findings. Despite this limitation, this is a timely 
study and reflects the psychological distress of  pregnant 
women in the face of  the spread of  COVID-19. 
In conclusion, a significant proportion of  pregnant women 
had psychological symptoms of  depression, anxiety and 
stress, during COVID-19-related lockdown in Nigeria. There 
is a need to pay special attention to vulnerable populations, 
such as pregnant women, so as to prevent long term adverse 
psychological outcomes that may arise from the COVID-19 
pandemic.
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